Get the Stockscreener App
195.70
2.93%
5.58
Ishares Biotechnology Etf stock is traded at $195.70, with a volume of 2.21M.
It is up +2.93% in the last 24 hours and up +19.13% over the past month.
See More
Previous Close:
$190.12
Open:
$191.6
24h Volume:
2.21M
Relative Volume:
1.50
Market Cap:
$9.09B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.55%
1M Performance:
+19.13%
6M Performance:
+15.80%
1Y Performance:
+51.06%
1-Day Range:
$190.92
$195.99
1-Week Range:
$183.51
$195.99
52-Week Range:
$127.11
$195.99
Ishares Biotechnology Etf Stock (IBB) Company Profile
Name
Ishares Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
195.70 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Stock (IBB) Latest News
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
Sector Update: Healthcare - Moomoo
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings (IBB:NASDAQ) - Seeking Alpha
DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Syntax Bio expands Series A to $14.4M, adds leadership and board members (IBB:NASDAQ) - Seeking Alpha
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - The Motley Fool
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Tevogen Bio Holdings Inc (TVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inozyme Pharma Inc (INZY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
IShares TrustiShares Biotechnology ETF announces Quarterly dividend, payable on June 18, 2026 - marketscreener.com
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
IBBm Holdings (iShares Biotechnology Cedear) - Investing.com
Sector Update: Healthcare Stocks Gain Friday Afternoon - Moomoo
BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval - TechStock²
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Friday After May Jobs Report - Moomoo
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat - TechStock²
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga
Sector Update: Healthcare Stocks Rise Premarket Thursday - Moomoo
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming - Bez Kabli
MacroGenics Shares Pop on 2028 Cash Runway Focus - Bez Kabli
Chemomab Drops After Board Changes and CEO Stock Purchase - Bez Kabli
DiaMedica Shares Down Ahead of Stroke Trial Update - Bez Kabli
Aura Biosciences Stock Falls After Eye-Cancer Trial News - Bez Kabli
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
Hot Money Rotates to Keep the Market Running - TheStreet Pro
Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN - Bez Kabli
Ligand Shares Hold Up in Biotech Rout While XOMA Deal Heads for Investor Vote - Bez Kabli
Ishares Biotechnology Etf Stock (IBB) Financials Data
There is no financial data for Ishares Biotechnology Etf (IBB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.82%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):